Characteristics of cases and controls
| Cases | Controls | |
|---|---|---|
| N | 44 | 220 |
| Age (years) (±SD) | 82.2 (6.7) | 82.2 (6.6) |
| Smoking (%) | ||
| Non-current smoker | 77.3 | 70.9 |
| Current smoker | 2.3 | 3.2 |
| Not recorded | 20.5 | 25.9 |
| Alcoholism | 0.0 | 0.0 |
| Body mass index (kg/m2) (±SD) | 29.4 (4.9) | 29.1 (5.3) |
| <20 kg/m2 (%) | 0.0 | 1.4 |
| 20–<25 kg/m2 (%) | 9.1 | 14.1 |
| 25–<30 kg/m2 (%) | 29.6 | 25.0 |
| >=30 kg/m2 (%) | 31.8 | 32.3 |
| Not recorded (%) | 29.6 | 27.1 |
| Comorbidities (%) | ||
| Previous fracture | 20.5 | 8.2 |
| Kidney disease | 4.6 | 5.0 |
| Malabsorption | 2.3 | 1.4 |
| Stroke | 9.1 | 6.4 |
| Dementia | 9.1 | 8.6 |
| Rheumatoid arthritis | 2.3 | 1.4 |
| Diabetes | 18.2 | 20.5 |
| Epilepsy | 2.3 | 0.5 |
| Parkinson disease | 0.0 | 1.8 |
| Thyroid disease | 9.1 | 13.2 |
| Use of medication (%) | ||
| PPI or H2 receptor blocker | 34.1 | 33.2 |
| Anxiolytic | 22.7 | 24.1 |
| Antidepressants | 9.1 | 19.6 |
| Antihypertensives | 50.0 | 60.9 |
| Oral corticosteroids | 4.6 | 7.3 |
| Sedatives | 9.1 | 6.8 |
| Raloxifene | 0.0 | 2.3 |
| Hormone replacement therapy | 0.0 | 0.0 |
| Thiazolidinedione | 0.0 | 0.0 |
Values correspond to percentage or means (SD).